TY  - GEN
AU  - Hambardzumyan,Karen
AU  - Bolce,Rebecca
AU  - Saevarsdottir,Saedis
AU  - Cruickshank,Scott E
AU  - Sasso,Eric H
AU  - Chernoff,David
AU  - Forslind,Kristina
AU  - Petersson,Ingemar F
AU  - Geborek,Pierre
AU  - van Vollenhoven,Ronald F
TI  - Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
SN  - 1468-2060
PY  - 2015///0728
KW  - Adipokines
KW  - metabolism
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - diagnostic imaging
KW  - Biomarkers
KW  - C-Reactive Protein
KW  - Chitinase-3-Like Protein 1
KW  - Disease Progression
KW  - Drug Therapy, Combination
KW  - Epidermal Growth Factor
KW  - Female
KW  - Foot Joints
KW  - Hand Joints
KW  - Humans
KW  - Hydroxychloroquine
KW  - Infliximab
KW  - Interleukin-6
KW  - Lectins
KW  - Leptin
KW  - Logistic Models
KW  - Male
KW  - Matrix Metalloproteinase 1
KW  - Matrix Metalloproteinase 3
KW  - Methotrexate
KW  - Multivariate Analysis
KW  - Prognosis
KW  - Radiography
KW  - Receptors, Tumor Necrosis Factor, Type I
KW  - Resistin
KW  - Serum Amyloid A Protein
KW  - Severity of Illness Index
KW  - Sulfasalazine
KW  - Treatment Outcome
KW  - Vascular Cell Adhesion Molecule-1
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/annrheumdis-2013-204986
ER  -